Scientists test Double-Punch therapy for Tough-to-Treat abdominal tumors
NCT ID NCT07396116
Summary
This study is testing a new two-part treatment for aggressive soft tissue cancers in the abdomen (retroperitoneal sarcoma). Doctors want to see if giving a short, intense course of radiation therapy combined with immunotherapy drugs before surgery is safe and feasible. The goal is to better control the cancer and reduce the chance it comes back after the tumor is removed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Radiotherapy Department of Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100021, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.